1. Home
  2. ARDX vs LGIH Comparison

ARDX vs LGIH Comparison

Compare ARDX & LGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$5.80

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo LGI Homes Inc.

LGIH

LGI Homes Inc.

HOLD

Current Price

$46.91

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARDX
LGIH
Founded
2007
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
ARDX
LGIH
Price
$5.80
$46.91
Analyst Decision
Strong Buy
Hold
Analyst Count
10
5
Target Price
$10.65
$71.13
AVG Volume (30 Days)
2.7M
332.3K
Earning Date
10-30-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
4.53
Revenue
$398,234,000.00
$1,788,933,000.00
Revenue This Year
$22.71
N/A
Revenue Next Year
$27.81
$17.77
P/E Ratio
N/A
$10.34
Revenue Growth
58.12
N/A
52 Week Low
$3.21
$39.70
52 Week High
$6.78
$109.87

Technical Indicators

Market Signals
Indicator
ARDX
LGIH
Relative Strength Index (RSI) 53.23 45.21
Support Level $5.73 $50.90
Resistance Level $6.20 $55.30
Average True Range (ATR) 0.29 2.52
MACD 0.01 -0.15
Stochastic Oscillator 57.78 32.93

Price Performance

Historical Comparison
ARDX
LGIH

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company have seven operating segments ( West, Northwest, Central, Midwest, Florida, Southeast and Mid-Atlantic) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.

Share on Social Networks: